Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus Type 1 (HIV-1) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Early research (Phase 1)Study completedNCT05144386
What this trial is testing

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Who this might be right for
HIV-1-infection
Excision BioTherapeutics 6
Large-scale testing (Phase 3)Study completedNCT03446573
What this trial is testing

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Who this might be right for
HIV Infections
ViiV Healthcare 743
Testing effectiveness (Phase 2)Study completedNCT00530777
What this trial is testing

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

Who this might be right for
HIV InfectionsHerpes Simplex
University of Washington 148
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Study completedNCT04802811
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects

Who this might be right for
HIV-1 Infection
Jiangsu HengRui Medicine Co., Ltd. 37
Large-scale testing (Phase 3)Study completedNCT00120393
What this trial is testing

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

Who this might be right for
HIV Infections
Bristol-Myers Squibb 192
Early research (Phase 1)Study completedNCT02599896
What this trial is testing

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
Prevention of HIV InfectionHIV AntibodiesMonoclonal Antibody, Human+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 49
Not applicableStudy completedNCT00351442
What this trial is testing

Examining Factors That May Influence Resistance to HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 522
Post-approval studies (Phase 4)Study completedNCT00207142
What this trial is testing

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Who this might be right for
HIV Infections
Bristol-Myers Squibb 252
Not applicableStudy completedNCT03579381
What this trial is testing

Specimen Repository for HIV Immunopathogenesis

Who this might be right for
HIV-1-infectionAcute HIV Infection
AIDS Healthcare Foundation 9
Post-approval studies (Phase 4)Study completedNCT04553081
What this trial is testing

2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

Who this might be right for
HIV-1-infection
University Hospital, Ghent 134
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Study completedNCT00454337
What this trial is testing

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 170
Testing effectiveness (Phase 2)Study completedNCT00251537
What this trial is testing

A Pilot Study of LTB4 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
LTB4 Sweden AB 40
Early research (Phase 1)Study completedNCT00069030
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableStudy completedNCT00000892
What this trial is testing

Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT00158457
What this trial is testing

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 40
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Large-scale testing (Phase 3)UnknownNCT00004981
What this trial is testing

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Who this might be right for
HIV Infections
Glaxo Wellcome 230
Next Page